Home / Stocks / ADVM

ADVM insider trading

Adverum Biotechnologies, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
9
Bought · 24 mo
$4.6M
Buys · last 90 days
0 · $0
Most recent buy
2025-12-08

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-12-08Fischer Laurent
CEO, PRESIDENT AND DIRECTOR
Bought128,699$4.30$554k
2025-12-08Soparkar Peter
CHIEF OPERATING OFFICER
Bought50,000$4.22$211k
2025-12-05Leonard Braden Michael
10% owner
Sold524,560$4.19$2.2M
2025-12-03Leonard Braden Michael
10% owner
Sold300,000$4.20$1.3M
2025-04-28Leonard Braden Michael
10% owner
Bought37,000$5.11$189k
2025-04-28Leonard Braden Michael
10% owner
Bought37,000$5.11$189k
2025-04-24Leonard Braden Michael
10% owner
Bought350,000$3.00$1.0M
2025-04-02Leonard Braden Michael
10% owner
Bought34,775$4.23$147k
2025-03-27Leonard Braden Michael
10% owner
Bought37,000$5.11$189k
2025-03-20Leonard Braden Michael
10% owner
Bought117,941$4.98$588k
2025-02-28Leonard Braden Michael
10% owner
Bought336,756$4.28$1.4M

Most active insider buyers

InsiderRoleBuysTotal bought
Leonard Braden Michael10% owner7$3.8M
Fischer LaurentCEO, PRESIDENT AND DIRECTOR1$554k
Soparkar PeterCHIEF OPERATING OFFICER1$211k

See ADVM on the chart

Every insider buy and sell for ADVM plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.